Cargando…
Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19()
BACKGROUND: This consensus aims to clarify the role of Dipeptidyl Peptidase-4 inhibitors (iDPP-4) in managing patients with diabetes during the COVID-19 pandemic. MATERIALS AND METHODS: A PubMed bibliographic search was carried out (December 2019–February 2021). Oxford methodology was used for the e...
Autores principales: | Carrasco-Sánchez, Francisco Javier, Carretero-Anibarro, Enrique, Gargallo, Manuel Ángel, Gómez-Huelgas, Ricardo, Merino-Torres, Juan Francisco, Orozco-Beltrán, Domingo, Pines Corrales, Pedro José, Ruiz Quintero, Manuel Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SEEN and SED. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853860/ https://www.ncbi.nlm.nih.gov/pubmed/35353681 http://dx.doi.org/10.1016/j.endien.2022.02.008 |
Ejemplares similares
-
Resumen Ejecutivo del Consenso de expertos sobre la eficacia y seguridad de los iDPP-4 en el tratamiento de pacientes con diabetes y COVID-19
por: Carrasco-Sánchez, Francisco Javier, et al.
Publicado: (2022) -
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
por: Calkins, Hugh, et al.
Publicado: (2018) -
Obesity and COVID-19. A necessary position statement()
por: Bretón, Irene, et al.
Publicado: (2021) -
Home blood pressure monitoring: Australian Expert Consensus Statement
por: Sharman, James E., et al.
Publicado: (2015) -
Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention
por: Volpe, Massimo, et al.
Publicado: (2022)